articleNew England Journal of MedicineJun 19, 2003BRONZE OA

Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer

Harvard University · Massachusetts General Hospital · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial-lymphatic fluid transport, could be used in conjunction with high-resolution magnetic resonance imaging (MRI) to reveal small nodal metastases.

Methods

Eighty patients with presurgical clinical stage T1, T2, or T3 prostate cancer who underwent surgical lymph-node resection or biopsy were enrolled. All patients were examined by MRI before and 24 hours after the intravenous administration of lymphotropic superparamagnetic nanoparticles (2.6 mg of iron per kilogram of body weight). The imaging results were correlated with histopathological findings.

No related works found for this paper.